This session discusses the Center for Drug Evaluation and Research’s (CDER) Quality Management Maturity (QMM) pilot program, which is designed to create an objective scale to measure the strength of pharmaceutical companies’ quality systems. The panelists will explain the scale and features of the QMM and how it intersects with GMP inspections.